Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2017.01.005
Abstract: Introduction The clinical relevance of Achromobacter xylosoxidans infection in cystic fibrosis (CF) remains controversial. This emerging agent in CF has been associated with increased lung inflammation, more frequent exacerbations and more severe lung disease. We… read more here.
Keywords: cystic fibrosis; achromobacter xylosoxidans; xylosoxidans infection; infection cystic ... See more keywords